error fb Gplus IN twitter down-arrow Email Phone Check-Mark padlock circle_arrow minus plus play_btn close Clipboard_Icon Shopping-Cart_Icon Speech_Bubble_Icon Stethoscope_Icon pharmacists menu left-arrow right-arrow facebook search cart



Dexcom Patient Assistance Program for US Patients During the COVID-19 Pandemic

The Dexcom Patient Assistance Program (“Program”) will be available to current U.S. customers who have lost their health insurance coverage as a result of the impact of the COVID-19 pandemic.* The Program will launch in the next several weeks and will be available during the COVID-19 pandemic in the United States.

For those existing U.S. customers who qualify for participation in Dexcom’s Program, Dexcom will offer:

  • Up to two shipments of 90-days of Dexcom continuous glucose monitoring (“CGM”) system supplies, with each shipment consisting of one transmitter and three boxes of three sensors
  • Reduce patient cost to $45 per 90-day supply shipment


*Patients that are eligible for coverage of their Dexcom CGM systems under a federal or state government program (such as Medicare, Medicaid or VA benefits) are not eligible to participate in this Program. Certain terms and conditions will apply to be eligible for participation in the Program, such as the submission of a complete Program application and documentation showing loss of healthcare benefits.


Dexcom Patient Assistance Program Interest Form


Please fill out the following form and click submit to receive ongoing (or up-to-date) information about this patient assistant program as it becomes available.


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.